These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 768993)

  • 1. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
    Jordon RE; McDuffie FC
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR; Moy RL; Chia D; Barnett EV
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement in pemphigus vulgaris and other bullous dermatoses.
    Sbano E; Auteri A; Fimiani M; Volpi L
    Arch Dermatol Res (1975); 1975 Dec; 254(2):143-8. PubMed ID: 56159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.
    Jordon RE; Day NK; Sams WM; Good RA
    J Clin Invest; 1973 May; 52(5):1207-14. PubMed ID: 4573354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
    Dainichi T; Chow Z; Kabashima K
    J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.
    Yamada H; Hashimoto T; Nishikawa T
    J Invest Dermatol; 1989 Apr; 92(4):585-7. PubMed ID: 2649595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotactic activity in the fluid of bullous pemphigoid blisters].
    Diáz Pérez JL; Jordon RE
    Med Cutan Ibero Lat Am; 1975; 3(6):465-70. PubMed ID: 778510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement activation in bullous skin diseases.
    Jordon RE
    J Invest Dermatol; 1975 Jul; 65(1):162-9. PubMed ID: 50385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
    Tappeiner G; Heine KG; Kahl JC; Jordon RE
    Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
    Jordon RE; Kawana S; Fritz KA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of bullous pemphigoid antibodies to basal cells.
    Nishikawa T; Kurihara S; Harada T; Hatano H
    J Invest Dermatol; 1980 Jun; 74(6):389-91. PubMed ID: 6991608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in pemphigus and bullous pemphigoid.
    Jordon RE
    J Invest Dermatol; 1976 Sep; 67(3):366-71. PubMed ID: 787432
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.
    Jeffes EW; Yamamoto RS; Ahmed AR; Granger GA
    J Clin Immunol; 1984 Jan; 4(1):31-5. PubMed ID: 6365950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
    Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
    J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody.
    Kelly SE; Cerio R; Bhogal BS; Black MM
    J Invest Dermatol; 1989 May; 92(5):695-8. PubMed ID: 2654296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.